Harwood A J, Shervington A, Bostock C J
AFRC Institute for Animal Health, Pirbright Laboratory, Woking, Surrey, U.K.
Gene. 1990 Apr 16;88(2):279-83. doi: 10.1016/0378-1119(90)90044-r.
A high-copy-number plasmid, pLink, was constructed to allow the direct selection in Escherichia coli of a neo fusion gene capable of conferring Geneticin (G418) resistance on mouse L cells. pLink was derived from pdMmtneo by insertion of a KpnI linker within the 5'-coding region of the neo gene. This created a minus-one frameshift mutation resulting in a translational termination within the N-terminal region of the protein. The Neo activity was restored by insertion into the modified neo gene of a piece of coding sequence derived from human HPRT cDNA. The resulting plasmid, pAH, was microinjected into mouse A9 cells and shown to confer resistance to G418.
构建了一种高拷贝数质粒pLink,以便在大肠杆菌中直接筛选能够赋予小鼠L细胞对遗传霉素(G418)抗性的新融合基因。pLink是通过在新霉素基因的5'-编码区内插入一个KpnI接头从pdMmtneo衍生而来。这产生了一个负一移码突变,导致蛋白质N端区域内的翻译终止。通过将一段源自人HPRT cDNA的编码序列插入修饰后的新霉素基因中,恢复了新霉素活性。将所得质粒pAH显微注射到小鼠A9细胞中,结果表明其赋予了对G418的抗性。